<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02369107</url>
  </required_header>
  <id_info>
    <org_study_id>XM201410</org_study_id>
    <nct_id>NCT02369107</nct_id>
  </id_info>
  <brief_title>The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting</brief_title>
  <official_title>A Multi-center,Randomized Controlled Clinical Trial: the Effect of Acupuncture in Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting on Patients With Malignancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Shijitan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Municipal Administration of Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Hospital of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nausea and vomiting are the most common symptoms experienced by cancer patients after
      chemotherapy. Some patients have to endure such unpleasant symptoms even after using of
      antiemetic or anti-vomiting medications.The purpose of this study is to assess the
      therapeutic effects and safety of acupuncture for chemotherapy-induced nausea and vomiting on
      patients with malignancy
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in severity of nausea and vomiting at 21 days</measure>
    <time_frame>It will be assessed at baseline,day1, day 2, day 3, day 7(±1)，day 10(±1), day 14(±1), day 21(±1).Patients have a daily questionnaire about nausea and vomiting during chemotherapy to record their feelings</time_frame>
    <description>The severity of nausea and vomiting will be assessed by the Common Terminology Criteria for Adverse Events (CTCAE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TCM symptoms scale</measure>
    <time_frame>It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.</time_frame>
    <description>to evaluate TCM syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECOG score scale</measure>
    <time_frame>It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.</time_frame>
    <description>to evaluate physical condition of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HADS</measure>
    <time_frame>It will be assessed at baseline, day3, day7(±1), day14(±1), day21(±1).Patients will be accessed with questionaire by doctors.</time_frame>
    <description>a questionnaire to access the anxiety levels of patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">136</enrollment>
  <condition>Chemotherapy-induced Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Verum acupuncture and medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ，6 hours after chemotherapy administration，and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham acupuncture and medicine</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Verum acupuncture and medicine</intervention_name>
    <description>Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ，6 hours after chemotherapy administration，and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz. They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).</description>
    <arm_group_label>Verum acupuncture and medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham acupuncture and medicine</intervention_name>
    <description>Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).</description>
    <arm_group_label>Sham acupuncture and medicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with definite pathological diagnosis of lung cancer, breast cancer, and
             gynecological cancer.They haven't receive any chemotherapy or radiotherapy treatment
             for three months prior to join this study.

          2. Aged 18-75.

          3. Patients will receive chemotherapy treatment which included Cisplatin, anthracycline
             or taxane during the study period.

          4. ECOG score is between 0 and 2.

          5. The patients are diagnosed with insufficiency of spleen-qi and stomach-qi,reverse
             ascending of Stomach-Qi in traditional Chinese medicine theory.

          6. The expected lifetime of the patient is longer than 6 months.

          7. Patients willing to participate in the study and sign the consent form.

        Exclusion Criteria:

          1. Patients have serious disease in cardiovascular system ,liver system,kidney system,
             immune systems and hemopoietic system.

          2. Pregnant and lactating women.

          3. Patients have intractable vomiting caused by malignant brain metastases, intracranial
             hypertention, digestive tract obstruction, severe liver or Renal dysfunction, brain
             tumors, cerebrovascular disease, or other reasons.

          4. Patients with Coagulopathy, thrombocytopenia, or suffering from bleeding disorders.

          5. Patients have been definitely diagnosed with depression, anxiety disorders and
             psychosis

          6. Patients with Sepsis or Bacteremia.

          7. Patients have lymphedema in acupuncture stimulation area.

          8. Patients who are afraid of acupuncture stimulation or allergic to stainless steel
             needles can't participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaomin Wang, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaomin Wang, Doctor</last_name>
    <phone>+86(010)52176508</phone>
    <email>wangxiaomin_bhtcm@126.com</email>
  </overall_contact>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2015</study_first_submitted>
  <study_first_submitted_qc>February 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2015</study_first_posted>
  <last_update_submitted>February 17, 2015</last_update_submitted>
  <last_update_submitted_qc>February 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Hospital of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Wang Xiaomin</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>chemotherapy-induced nausea and vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

